Occudo Quantitative Strategies’s Quest Diagnostics DGX Stock Holding History

Occudo Quantitative Strategies’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,708	Closed	-$1.06M	–	799
2023 Q4	$1.06M	Buy	7,708 +3,894	+102%	+$512K	0.14%	192
2023 Q3	$465K	Buy	+3,814	New	+$508K	0.06%	528
2022 Q3	–	Sell	-30,267	Closed	-$4.03M	–	1238
2022 Q2	$4.03M	Buy	30,267 +3,445	+13%	+$469K	0.33%	59
2022 Q1	$3.67M	Sell	26,822 -1,828	-6%	-$255K	0.31%	57
2021 Q4	$4.96M	Buy	28,650 +19,918	+228%	+$3.03M	0.44%	31
2021 Q3	$1.27M	Buy	+8,732	New	+$1.28M	0.15%	191
2021 Q2	–	Sell	-12,739	Closed	-$1.64M	–	911
2021 Q1	$1.64M	Buy	12,739 +10,460	+459%	+$1.29M	0.36%	50
2020 Q4	$272K	Buy	+2,279	New	+$278K	0.09%	448

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Occudo Quantitative Strategies's DGX Position: Q1 2024 in Review

Occudo Quantitative Strategies sold out of Quest Diagnostics (DGX) in Q1 2024, closing a stake of 7,708 shares — an estimated $1.06M sold.

Occudo Quantitative Strategies first reported a position in DGX in Q4 2020 and held it in 8 quarters. The position peaked at $4.96M in Q4 2021. 818 funds tracked by Wall St. Rank hold DGX as of Q1 2024.

Occudo Quantitative Strategies reported no remaining Quest Diagnostics position as of Q1 2024 after selling out during the quarter.
Occudo Quantitative Strategies sold 7,708 Quest Diagnostics shares in Q1 2024, an estimated $1.06M.
Occudo Quantitative Strategies first reported a position in Quest Diagnostics in Q4 2020 and held it in 8 quarters.
Occudo Quantitative Strategies's Quest Diagnostics position peaked at $4.96M in Q4 2021.
818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2024, filed 15 May 2024.